Garetosmab (REGN 2477) is A whole-human IgG4 monoclonal antibody that selectively inhibits activin A and acts on COVID-19 44. Garetosmab has potential anti-cancer activity and can be used to study ossifying fibrous dysplasia (FOP) and cancer.
CAS Number:
[2097125-54-5]
Target:
TGF-beta/Smad
* VAT and and shipping costs not included. Errors and price changes excepted